
New Data Suggest HCV Remains a Problem in the US
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in the US
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in the US
Ken Olovich, R.Ph., MBA, Sourcing and Financial Director of Chorus, Eli Lilly, explains a model of budget transparency with CROs…
Peter Shapiro, Editor-In-Chief, PharmSource, a GlobalData Product, assesses key trends currently changing the face of the contract manufacturing industry
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, covers developments from the recent World Antibiotic Awareness Week
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges involved in handling cryogenic pharmaceutical products
Monir El Azzouzi, Quality Operation Manager, Johnson & Johnson, explains what is needed for a Software as a Medical Device
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient recruitment and retention in Latin…
Thank you for subscribing to Clinical Trials Arena